- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.79 Å
- Oligo State
- monomer
- Ligands
- 1 x PRO: PROLINE(Non-covalent)
- 1 x MU5: ~{N}-(2,3-dihydro-1~{H}-inden-2-yl)-3-(piperidin-1-ylcarbonylamino)pyrazine-2-carboxamide(Non-covalent)
MU5.2: 19 residues within 4Å:- Chain A: R.148, E.150, K.152, Q.153, P.154, F.157, I.158, R.159, T.160, R.161, F.163, W.165, Q.233, T.236, G.268, T.270, R.272
- Ligands: PRO.1, EDO.18
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:R.148, A:E.150, A:E.150, A:K.152, A:R.159, A:W.165, A:T.236
- Hydrogen bonds: A:T.160, A:T.160, A:T.270, A:R.272
- pi-Stacking: A:F.163
- 21 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 4 residues within 4Å:- Chain A: S.21, Y.24, M.279, Y.504
Ligand excluded by PLIPEDO.4: 3 residues within 4Å:- Chain A: Y.51, E.54, C.55
Ligand excluded by PLIPEDO.5: 6 residues within 4Å:- Chain A: K.16, E.227, T.280, H.281, G.282, K.409
Ligand excluded by PLIPEDO.6: 6 residues within 4Å:- Chain A: A.48, L.289, S.294, K.295, Y.296, I.353
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: E.63, K.66, R.191
- Ligands: EDO.17, EDO.22
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: N.61, K.65, V.69, E.70, N.71
Ligand excluded by PLIPEDO.9: 7 residues within 4Å:- Chain A: K.206, E.210, T.218, Q.233, T.236, H.238
- Ligands: EDO.18
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: I.205, P.475, L.476, Q.478, R.496
- Ligands: EDO.11
Ligand excluded by PLIPEDO.11: 4 residues within 4Å:- Chain A: F.183, I.205, F.217
- Ligands: EDO.10
Ligand excluded by PLIPEDO.12: 2 residues within 4Å:- Chain A: R.190, K.203
Ligand excluded by PLIPEDO.13: 1 residues within 4Å:- Chain A: P.95
Ligand excluded by PLIPEDO.14: 7 residues within 4Å:- Chain A: K.285, E.349, R.356, V.372, R.373, R.374, N.377
Ligand excluded by PLIPEDO.15: 4 residues within 4Å:- Chain A: T.242, Q.260, Y.261, H.263
Ligand excluded by PLIPEDO.16: 3 residues within 4Å:- Chain A: V.179, K.180, F.183
Ligand excluded by PLIPEDO.17: 5 residues within 4Å:- Chain A: K.62, E.63, K.66, R.191
- Ligands: EDO.7
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: Q.233, R.272, Y.504
- Ligands: MU5.2, EDO.9
Ligand excluded by PLIPEDO.19: 3 residues within 4Å:- Chain A: R.336, A.337, S.338
Ligand excluded by PLIPEDO.20: 2 residues within 4Å:- Chain A: V.29, K.30
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain A: Y.36, Y.37, D.38
Ligand excluded by PLIPEDO.22: 5 residues within 4Å:- Chain A: L.67, D.184, D.187, L.188
- Ligands: EDO.7
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain A: Y.133, L.136, P.137, K.173, E.177
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johansson, C. et al., Crystal Structure of Prolyl-tRNA synthetase (ProRS, Proline--tRNA ligase) from Plasmodium falciparum in complex with NCP-26 and L-Proline. To Be Published
- Release Date
- 2020-11-18
- Peptides
- Proline--tRNA ligase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.79 Å
- Oligo State
- monomer
- Ligands
- 1 x PRO: PROLINE(Non-covalent)
- 1 x MU5: ~{N}-(2,3-dihydro-1~{H}-inden-2-yl)-3-(piperidin-1-ylcarbonylamino)pyrazine-2-carboxamide(Non-covalent)
- 21 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Johansson, C. et al., Crystal Structure of Prolyl-tRNA synthetase (ProRS, Proline--tRNA ligase) from Plasmodium falciparum in complex with NCP-26 and L-Proline. To Be Published
- Release Date
- 2020-11-18
- Peptides
- Proline--tRNA ligase: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A